MedTrace Logo

Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract

NCT04262453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2023-11-07

No results posted yet for this study

Summary

Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract.

The patient follows a usual course of care including, at the end of the treatment of his cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and ventilatory polygraphy)

Conditions

  • Upper Aerodigestive Tract Neoplasms
  • Obstructive Sleep Apnea-hypopnea Syndrome

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Sandrine Baron, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2023-09-20
Completion
2023-09-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04262453 on ClinicalTrials.gov